Optimal dose of bone marrow mesenchymal stem cell transplantation for experimental ulcerative colitis
The density 5 × 10<sup>6</sup> is proper of bone mesenchymal stem cells for treatment of ulcerative colitis.
Authors
- Yangsheng Liu (ORCID: https://orcid.org/0000-0002-4490-3004)
- Ying Xia (ORCID: https://orcid.org/0000-0002-0126-6594)
- Lingzhi Qin (ORCID: https://orcid.org/0000-0003-4958-5241)
- Min Min (ORCID: https://orcid.org/0000-0003-1519-5069)
- Xiaohong Chen (ORCID: https://orcid.org/0000-0002-9797-8384)
Institutions
- Xianning Central Hospital (CN)
- Hubei University of Science and Technology (CN)
- Wuhan No.1 Hospital (CN)
- Wuhan No.9 Hospital (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Regenerative Therapy
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1016/j.reth.2025.01.015
- Citations
- 1
- Primary Topic
- Mesenchymal stem cell research
- Type
- article
- Field-Weighted Citation Impact
- 1.63